Inozyme Pharma Inc Headquarters
Looking for information about Inozyme Pharma Inc Headquarters? The links below have collected all the necessary data.
Inozyme Pharma Corporate Website - Inozyme Pharma
- https://www.inozyme.com/
- Aug 11, 2021 · Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue, and skeleton that can be life-threatening and debilitating. Navigation. Company. Science.
Contact Information for Questions About Inozyme …
- https://www.inozyme.com/contact/
- Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue, and skeleton that can be life-threatening and debilitating. Navigation. Company. Science.Estimated Reading Time: 1 min
Inozyme - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/inozyme
- Headquarters Regions Greater Boston Area, East Coast, New England; Founded Date 2016; Founders Axel Bolte, Eric Yuen, Steven Jungles; Operating Status Active; Last Funding Type Series A; Also Known As Inozyme Pharma; Legal Name Inozyme Pharma, Inc. Stock Symbol NASDAQ:INZY ; Company Type For Profit; Contact Email [email protected]; Phone Number +1 (857) 330-4340Founded: 2016
Investors & News - Inozyme Pharma, Inc.
- https://investors.inozyme.com/
- May 13, 2021 · Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization. Through our in-depth understanding of the biological pathways involved in mineralization, we are pursuing the development of therapeutics to address the underlying causes of these debilitating diseases.
Corporate Governance - Inozyme Pharma, Inc.
- https://investors.inozyme.com/corporate-governance/governance-overview
- Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue, and skeleton that can be life-threatening and debilitating. Navigation. Company. Science.
Information About Inozyme Pharma’s Investors - Inozyme …
- https://www.inozyme.com/company/investors/
- Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue, and skeleton that can be life-threatening and debilitating. Navigation. Company. Science.
Inozyme Pharma Appoints Kevin B. Johnson, Ph.D., MBA, as ...
- https://investors.inozyme.com/news-releases/news-release-details/inozyme-pharma-appoints-kevin-b-johnson-phd-mba-senior-vice
- Nov 09, 2020 · BOSTON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton, today announced the appointment of Kevin B. Johnson, Ph.D., MBA, as senior vice president, regulatory …
Have you found Inozyme Pharma Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.